Save Comparison | ![]() EpiVax EpiVax has developed comprehensive analytical capabilities in the field of computational immunology. | ![]() Transgene Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. | ![]() DBV Technologies We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. | |
Founding Date | Founding Date 2008 | Founding Date 1998 | Founding Date N/A | Founding Date 2002 |
Type | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Irvine, US HQ | Locations Providence, US HQ | Locations Illkirch, FR HQ Shanghai, CN Lyon, FR Boston, US | Locations Montrouge, FR HQ Bagneux, FR New York, US Summit, US |
Employees | Employees 7 | Employees 343% increase | Employees 1392% increase | Employees 311 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 256.1 m | Valuation ($) 616.4 m |
Twitter followers | Twitter followers 546 | Twitter followers 379 | Twitter followers 1.4 k | Twitter followers 1.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 14 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 0.5 | Average likes per tweet (last 30 days) 2.5 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 50% | Percentage of tweets with engagement (last 30 days) 71.43% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 271194 | Alexa Website Rank 361738 | Alexa Website Rank 221574 | Alexa Website Rank 292854 |
Employee Rating | Employee Rating N/A | Employee Rating 3.9 | Employee Rating 4.4 | Employee Rating 3.4 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised N/A | Total funding raised $ 28.2m |
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
View companyTransgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.
View companyWe are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
View company